Antiproliferative effect of rapamycin on growth factor-stimulated human adult lung fibroblasts in vitro may explain its superior efficacy for prevention and treatment of allograft obliterative airway disease in vivo

被引:35
作者
Nair, RV
Huang, X
Shorthouse, R
Adams, B
Brazelton, T
BraunDullaeus, R
Morris, RE
机构
[1] STANFORD UNIV, SCH MED, DEPT CARDIOVASC MED, STANFORD, CA 94305 USA
[2] UNIV ARIZONA, COLL MED, DEPT GEN SURG, TUCSON, AZ USA
关键词
D O I
10.1016/S0041-1345(96)00325-9
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:614 / 615
页数:2
相关论文
共 3 条
[1]  
HERTZ MI, 1993, AM J PATHOL, V142, P1945
[2]  
MORRIS RE, 1991, IMMUNOL TODAY, V12, P137
[3]  
Valentine VG, 1996, J HEART LUNG TRANSPL, V15, P371